Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/238155
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Hardy, Timothy | - |
dc.contributor.author | Wonders, Kristy | - |
dc.contributor.author | Younes, Ramy | - |
dc.contributor.author | Aithal, Guruprasad P. | - |
dc.contributor.author | Aller, Rocío | - |
dc.contributor.author | Allison, Michael | - |
dc.contributor.author | Bedossa, Pierre | - |
dc.contributor.author | Betsou, Fay | - |
dc.contributor.author | Boursier, Jerome | - |
dc.contributor.author | Brosnan, M. Julia | - |
dc.contributor.author | Burt, Alastair | - |
dc.contributor.author | Cobbold, Jeremy | - |
dc.contributor.author | Cortez-Pinto, Helena | - |
dc.contributor.author | Day, Chris P. | - |
dc.contributor.author | Dufour, Jean-François | - |
dc.contributor.author | Ekstedt, Mattias | - |
dc.contributor.author | Francque, Sven | - |
dc.contributor.author | Harrison, Stephen A. | - |
dc.contributor.author | Miele, Luca | - |
dc.contributor.author | Nasr, Patrik | - |
dc.contributor.author | Papatheodoridis, George | - |
dc.contributor.author | Petta, Salvatore | - |
dc.contributor.author | Tiniakos, Dina | - |
dc.contributor.author | Torstenson, Richard | - |
dc.contributor.author | Valenti, Luca | - |
dc.contributor.author | Holleboom, Adriaan G. | - |
dc.contributor.author | Yki-Järvinen, Hannele | - |
dc.contributor.author | Geier, Andreas | - |
dc.contributor.author | Romero-Gómez, Manuel | - |
dc.contributor.author | Ratziu, Vlad | - |
dc.contributor.author | Bugianesi, Elisabetta | - |
dc.contributor.author | Schattenberg, Jörn M. | - |
dc.contributor.author | Anstee, Quentin M. | - |
dc.date.accessioned | 2021-04-14T16:20:12Z | - |
dc.date.available | 2021-04-14T16:20:12Z | - |
dc.date.issued | 2020-11 | - |
dc.identifier.citation | Contemporary Clinical Trials 98: 106175 (2020) | - |
dc.identifier.uri | http://hdl.handle.net/10261/238155 | - |
dc.description | © 2020 The Author(s). | - |
dc.description.abstract | Non-Alcoholic Fatty Liver Disease (NAFLD), a progressive liver disease that is closely associated with obesity, type 2 diabetes, hypertension and dyslipidaemia, represents an increasing global public health challenge. There is significant variability in the disease course: the majority exhibit only fat accumulation in the liver but a significant minority develop a necroinflammatory form of the disease (non-alcoholic steatohepatitis, NASH) that may progress to cirrhosis and hepatocellular carcinoma. At present our understanding of pathogenesis, disease natural history and long-term outcomes remain incomplete. There is a need for large, well characterised patient cohorts that may be used to address these knowledge gaps and to support the development of better biomarkers and novel therapies. The European NAFLD Registry is an international, prospectively recruited observational cohort study that aims to establish a large, highly-phenotyped patient cohort and linked bioresource. Here we describe the infrastructure, data management and monitoring plans, and the standard operating procedures implemented to ensure the timely and systematic collection of high-quality data and samples. Already recruiting subjects at secondary/tertiary care centres across Europe, the Registry is supporting the European Union IMI2-funded LITMUS ‘Liver Investigation: Testing Marker Utility in Steatohepatitis’ consortium, which is a major international effort to robustly validate biomarkers that diagnose, risk stratify and/or monitor NAFLD progression and liver fibrosis stage. The European NAFLD Registry has the demonstrable capacity to support research and biomarker development at scale and pace. | - |
dc.description.sponsorship | The European NAFLD Registry is supported by the LITMUS (Liver Investigation: Testing Biomarker Utility in Steatohepatitis) consortium funded by the European Union Innovative Medicines Initiative 2 (IMI2) Joint Undertaking under grant agreement 777377, which receives support from the Horizon 2020 Framework Program of European Union and EFPIA. It has also received support from the EPoS (Elucidating Pathways of Steatohepatitis) consortium funded by the Horizon 2020 Framework Program of the European Union under Grant Agreement 634413, the FLIP consortium funded by the Framework Program 7 of the European Union under grant agreement 241762, and an EASL Registry Grant from the European Association for the Study of the Liver. | - |
dc.language | eng | - |
dc.publisher | Elsevier | - |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/777377 | - |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/634413 | - |
dc.relation | info:eu-repo/grantAgreement/EC/FP7/241762 | - |
dc.relation.isversionof | Publisher's version | - |
dc.rights | openAccess | - |
dc.title | The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease | - |
dc.type | artículo | - |
dc.identifier.doi | 10.1016/j.cct.2020.106175 | - |
dc.relation.publisherversion | http://dx.doi.org/10.1016/j.cct.2020.106175 | - |
dc.identifier.e-issn | 1551-7144 | - |
dc.date.updated | 2021-04-14T16:20:13Z | - |
dc.rights.license | http://creativecommons.org/licenses/by/4.0/ | - |
dc.contributor.funder | Innovative Medicines Initiative | - |
dc.contributor.funder | European Commission | - |
dc.relation.csic | Sí | - |
dc.identifier.funder | http://dx.doi.org/10.13039/501100010767 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100000780 | es_ES |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.grantfulltext | open | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | artículo | - |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
European_Hardy_PV_Art2020.pdf | 1,56 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
67
checked on 18-may-2024
WEB OF SCIENCETM
Citations
56
checked on 22-feb-2024
Page view(s)
105
checked on 29-may-2024
Download(s)
99
checked on 29-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons